Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
Hanna A Zielinska,1 Amit Bahl,2 Jeff MP Holly,1 Claire M Perks1 1IGFs and Metabolic Endocrinology Group, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol, UK; 2Department of Clinical Oncology, Bristol Haematology and Oncology Centre, Un...
Guardado en:
Autores principales: | Zielinska HA, Bahl A, Holly JMP, Perks CM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/902c945b429a42748d1e1bb6f60e74c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of Growth Velocity with Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Children with a Vegan Diet
por: Arie Purwana, et al.
Publicado: (2020) -
How ligand binds to the type 1 insulin-like growth factor receptor
por: Yibin Xu, et al.
Publicado: (2018) -
Insulin-like growth factor I and its binding protein-3 are regulators of lactation and maternal responsiveness
por: András H. Lékó, et al.
Publicado: (2017) -
Structural basis of the activation of type 1 insulin-like growth factor receptor
por: Jie Li, et al.
Publicado: (2019) -
Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma.
por: Zheng Liang, et al.
Publicado: (2014)